BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201110T103000
DTEND;TZID=Europe/London:20201110T113000
DTSTAMP:20260410T114231
CREATED:20200907T094450Z
LAST-MODIFIED:20200907T094450Z
UID:18349-1605004200-1605007800@staging.medilinkmidlands.com
SUMMARY:Webinar: The Value of Digital Health
DESCRIPTION:Digital Healthcare has undergone a dramatic acceleration during 2020. The requirement to deliver care remotely has accelerated adoption of new technologies\, new care pathways and new learning like never before. \nThis event is in partnership with the Digital Health Team at De Montfort University will provide an insight into the latest developments in this area\, supporting the future of healthcare. \nThis webinar will cover: \n-Examples of real-world application of digital technology in health and social care. \n-Examining the challenges and solutions to enhancing equitable access. \n-Exploring the benefits of digital health for patients\, healthcare professionals\, and society. \n-Understanding how partner organisations can demonstrate their digital health intervention delivers value. \nThis webinar is open to all organisations keen to explore and understand the digital health landscape. \nDuration: 1 hour \nThis free to attend webinar will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. For further details please click here. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nThe webinar is part of the programme of events for Leicester Business Festival 2020\, De Montfort University are proud to be Headline Partner. For further details on the festival\, please click here. \nSpeaker Profiles: \n \nDr Simon Oldroyd\, Interim Deputy Vice-Chancellor \nDr Simon Oldroyd is the University’s Interim Deputy Vice-Chancellor (iDVC).  Simon is Deputy to the Interim Vice-Chancellor on all academic matters.  His responsibilities include day-to-day academic leadership of the university and strategic and operational oversight and line management of the faculty Pro Vice-Chancellor/Deans and three cross cutting Pro Vice-Chancellor portfolios. \n  \n  \n  \n \nProfessor David Mba\, Pro Vice-Chancellor (Research and Enterprise) \nProfessor David Mba was appointed Pro Vice-Chancellor and Dean of Computing\, Engineering and Media in August 2017. In May 2019\, he also took on the role of PVC (Enterprise)\, and in March 2020 he also took on the role of PVC (Research). \nDavid’s current research is focused on machine condition monitoring\, machine fault diagnosis\, model based prognostics and machine performance prediction. \n  \n  \n \nProfessor Bertha Ochieng\, Professor of Integrated Health and Social Care \nBertha Ochieng is Professor of Integrated Health and Social Care\, Faculty of Health and Life Sciences\, De Montfort University. A key aspect of her research is in examining digital solutions that support development of integrated models of health and social care and community engagement. \n  \n  \n  \n  \nProfessor Barnaby Poulton\, MRPharmS FFCI; Hon. Professor of Digital Medicine and Director Digital Health and Care Unit. Digital Health Strategist \nBarnaby is a pharmacist by training who has switched his focus to digital health.  He has built and led multiple digital health companies and co-founded the Digital Health and Care Unit at DMU to support the evaluation of novel technologies\, enabling them to enter market and deliver benefits to patients. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-the-value-of-digital-health/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/colour-landscape-2-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201103T110000
DTEND;TZID=Europe/London:20201103T120000
DTSTAMP:20260410T114231
CREATED:20200916T063905Z
LAST-MODIFIED:20200916T063905Z
UID:18366-1604401200-1604404800@staging.medilinkmidlands.com
SUMMARY:Webinar: Medicines Management in Professional Sport
DESCRIPTION:Join Medilink East Midlands\, in partnership with MedsOnTrack and JensonR+ to discuss Medicines Management in Professional Sport. \nOur speaker\, Steve Simbler\, is a pharmacist with over 20 years’ experience working in elite sport. Steve will share some of his experiences as one of the lead pharmacists for the London 2012 Olympics and Paralympics\, as well as some of the other events with which he has been involved. He will also describe his work with elite teams in various sports\, including topics such as: \n• the volumes of analgesics and anti-inflammatories taken by players/athletes\n• storage and security issues in training grounds and also associated with travel\n• lack of full time doctors in professional sport and problems associated with other healthcare professionals administering medications to players\n• record-keeping issues\n• controlled drugs issues\n• emergency & trauma medications management in a sports environment\n• lack of regulatory oversight or independent monitoring\n• concerns over doping issues \nDURATION: 1 HOUR \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants \nSpeaker Profiles: \n \nSteve Simler MRPharm.s\, MedsOnTrack \nSteve has been working as a pharmacist in elite sport for over 20 years\, initially in a supply capacity\, and for the past 10 years in providing medicines management consultancy and software to teams in the Premier League and English Football League as well as national governing bodies for football\, rugby\, athletics\, tennis\, cricket\, rowing\, and cycling amongst others.\nHe was one of the lead pharmacists for the London 2012 Olympics and Paralympics\, then again for the London 2017 Athletics and Para-Athletics World Championships.\nAs well as giving talks about vitamin D\, he lectures on various topics pertaining to drugs in sport and the use of analgesics and anti-inflammatories in sport.\nIn 2006\, sport doctors approached Steve to advise on obtaining a reliable source of vitamin D that could pass tests for WADA-prohibited substances\, this prompted an association with Synergy Biologics\, makers of Pro D3\, and this relationship is ongoing\, and stimulated an interest in vitamin D on which he keeps abreast of research\, and reads extensively.\nSince 2016 Steve has been a pharmacist panel member for the General Pharmaceutical Council’s Fitness to Practise Committee\, and has recently started as an NHS Test and Trace clinical contact tracer on a part time basis. \n \nJanet Worrell\, Head of Regulatory\, JensonR+ \nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS.
URL:https://staging.medilinkmidlands.com/event/webinar-medicines-management-in-professional-sport/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201029T110000
DTEND;TZID=Europe/London:20201029T120000
DTSTAMP:20260410T114231
CREATED:20200824T083913Z
LAST-MODIFIED:20200824T083913Z
UID:18337-1603969200-1603972800@staging.medilinkmidlands.com
SUMMARY:Webinar: Food Supplements Special Interest Group (SIG)- CBD and the latest developments
DESCRIPTION:Join us online for our next Food Supplements Special Interest Group (SIG) to hear about how\, within the space of a couple of years\, CBD ingestibles have transitioned from a lightly regulated consumer product to potentially being classified as a narcotic and banned from the shelves of retail outlets in Europe. How did this happen and what’s the impact on the CBD industry? \nWe invite you to hear some of the facts around CBD\, providing clarity about its current status and the future challenges and opportunities for companies operating in this sector. All of this will be presented by our speakers\, Janet Worrell\, Head of Regulatory at JensonR+ and Greer Deal\, Director of Global Regulatory Services \nAs well as the opportunity to hear some facts about CBD you can take part in a question and answer session. \nDURATION: 1 Hour \nTO BOOK YOUR PLACE PLEASE CLICK HERE\nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nJanet Worrell\, Head of Regulatory\, JensonR+ \nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS. \n  \nGreer Deal\, Director\, Global Regulatory Services \nGreer has over 25 years’ experience in the life science sector and 13 years ago she co-founded Global Regulatory Services with her husband\, Bobby Deal. One of their first projects involved medicinal cannabis and since then the company has become increasingly involved in plant-derived products whether medicinal\, food or cosmetics. Since January 2019\, Global Regulatory Services has become known as the leading advisers to companies in the cannabis industry with particular expertise in navigating the EU Novel Foods Regulation.
URL:https://staging.medilinkmidlands.com/event/webinar-food-supplements-special-interest-group-sig-cbd-and-the-latest-developments/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Greer-Deal.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201022T103000
DTEND;TZID=Europe/London:20201022T120000
DTSTAMP:20260410T114231
CREATED:20200922T131336Z
LAST-MODIFIED:20200922T131336Z
UID:18375-1603362600-1603368000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The Nottingham Recovery from COVID-19 Research Platform (NoRCoRP) - Developing New Approaches to Treatment
DESCRIPTION:Researchers in Nottingham have launched a new study platform for the next generation of COVID-19 clinical research: The Nottingham Recovery from COVID-19 Research Platform (NoRCoRP). \nThe platform will bring together projects examining the impacts and lasting effects of COVID-19\, translating findings from patients who are known to have contracted the virus into new approaches to treatment to support their recovery. To read about the background on all of the Nottingham Biomedical Research Centre’s COVID-19 research\, click here. \nAttend this webinar to find out about NoRCoRP plus: \n– Background to COVID-19: clinical presentations\, pathophysiology\n– Existing treatment strategies\n– Review of Nottingham portfolio of existing clinical trial and planned clinical studies in patients with COVID-19\n– PHOSP-COVID and NoRCoRP: follow up studies of patients who have had COVID-19\n– Opportunities for engagement with the NIHR Nottingham BRC for COVID related work \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profile: \n\nProfessor Ian Hall\, Director\, NIHR Nottingham Biomedical Research Centre \nProfessor Ian is the Director of the NIHR Nottingham\, Biomedical Research Centre. He is a chest physician based at NUH NHS Trust and the University of Nottingham\, and has a long track record of research into the mechanisms underlying the development of a range of lung diseases. He currently chairs the national BRC Director’s forum\, sits on NIHR Strategy Board\, and is a member of UK-CTAP.
URL:https://staging.medilinkmidlands.com/event/webinar-the-nottingham-recovery-from-covid-19-research-platform-norcorp-developing-new-approaches-to-treatment/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Ian-Hall-scaled.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201021T103000
DTEND;TZID=Europe/London:20201021T113000
DTSTAMP:20260410T114231
CREATED:20200820T075208Z
LAST-MODIFIED:20200820T075208Z
UID:18334-1603276200-1603279800@staging.medilinkmidlands.com
SUMMARY:Webinar: Introduction to NHS Market Access
DESCRIPTION:Join our two-part CPD accredited virtual workshop\, Introduction to NHS Market Access\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nCombined\, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS. \nPART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– The NHS Structure \n– Understanding pathways and cash flow \n– Getting your message right \n– What support you can expect from the AHSN \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Wednesday 21st October. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \n  \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE:  \nNicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://staging.medilinkmidlands.com/event/webinar-introduction-to-nhs-market-access/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201020T140000
DTEND;TZID=Europe/London:20201020T150000
DTSTAMP:20260410T114231
CREATED:20200930T073818Z
LAST-MODIFIED:20200930T073818Z
UID:18380-1603202400-1603206000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Supply Chain - improving resilience and agility for challenging times
DESCRIPTION:This webinar alongside Mills & Reeve will consider how supply chains are evolving and adapting in these difficult times\, and what you can do to improve your crisis-resilience. \nFor all businesses\, the challenges of the COVID-19 crisis and the forthcoming end of the Brexit transition period present particular difficulties. For life sciences business\, an additional set of considerations arise. With multinational clinical studies\, complex global supply chains and multi-component products a well-planned approach is essential. The COVID-19 pandemic has brought these issues into sharp focus\, as countries battle for scarce supplies of active ingredients\, medicines\, reagents and equipment to enable them to support the effort to combat the outbreak. \nJayne Hussey and Stephanie Caird from Mills & Reeve will cover: \n– How businesses can build supply chain resilience and agility \n– Offer some tips on how to get ahead of a crisis before it happens \n– How some businesses are adopting new ways of working to tackle some of the financial difficulties of disrupted supply chains \n– How to build really effective relationships with your key suppliers \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n \nStephanie Caird\, Principal Associate\, commercial lawyer specialising in the life sciences sector\, Mills & Reeve\nStephanie is a lawyer specialising in the life sciences practice with experience in intellectual property\, data protection\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors.\nStephanie has also worked in-house for various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaboration and Brexit intra-group arrangements. \n\nJayne Hussey\, Partner\, commercial contracts specialist\, Mills & Reeve\nJayne is a commercial contracts specialist lawyer with a wealth of experience in advising businesses on complex supply chain arrangements\, including outsourcing contracts\, contract manufacturing arrangements and long term supply and purchasing arrangements. Jayne has international contracting expertise and has worked on a significant number of cross-border arrangements.\nJayne is highly regarded by clients for providing straightforward legal advice and support and ensuring that contractual arrangements are structured to deliver objectives. She is trusted by clients to assess proposed contracts in the context of a client’s appetite for risk and its governance framework.
URL:https://staging.medilinkmidlands.com/event/webinar-supply-chain-improving-resilience-and-agility-for-challenging-times/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/jayne-hussey.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201014T100000
DTEND;TZID=Europe/London:20201014T113000
DTSTAMP:20260410T114231
CREATED:20200213T124632Z
LAST-MODIFIED:20200213T124632Z
UID:18069-1602669600-1602675000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Additive Manufacturing & 3D Printing Special Interest Group (SIG)
DESCRIPTION:The Additive Manufacturing & 3D Printing Special Interest Group (SIG) is back and we have a great online event lined up for you on “Where are we now?”. \nThis event is in partnership with The University of Nottingham – Centre for Additive Manufacturing. The webinar will cover: \n– “Where are we now?”\n– The national additive manufacturing strategy: unleashing the potential in the medtech sector\n– Regulatory considerations for Additive Manufactured Medical Devices \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles \n\nRuth Goodridge\, Professor in Additive Manufacturing (3D Printing)\, The University of Nottingham \nRuth is Professor of Additive Manufacturing (3D-Printing) at the University of Nottingham. She is currently on secondment to Nottingham University Hospitals NHS Trust\, based in Clinical Engineering. With a degree in Biomaterials and PhD in Bioengineering\, she has a particular interest in the medical applications of Additive Manufacturing\, including assistive and rehabilitation devices (inc. prosthetics)\, implants and diagnostics. She has 20 years experience in multidisciplinary research into Additive Manufacturing\, including a 2-year JSPS fellowship held at NAIST\, Japan. Her expertise lies in material development for AM and advancing understanding of coupled material-processing aspects\, in particular for polymer and glass powder bed fusion. \n\nPaul Unwin\, Industrial Chair\, Additive Manufacturing Strategy Steering Group (AM UK) \nAM UK is an independent\, government-backed collaboration\, positioned to help drive the UK’s AM strategy. The national strategy published in September 2017 provides recommendations to enable UK industry to unlock the full commercial potential of additive manufacturing and presents the output of 5 years of work undertaken by the UK AM community.\nPreviously\, Paul was the founding CEO of the Stanmore Implants Worldwide Ltd\, who are a world renowned specialist orthopaedic implant service provider. Paul was the creator and architect of a ground-breaking patient-specific implant system that integrated patient imaging\, implant design\, implant manufacture utilising Additive Manufacturing and placing the implants with the aid of robotics\, culminating in the successful surgical placement – a world first. Paul and his team began investigating additive manufacturing for orthopaedic implants in 2006 and after following an extensive development programme built and implanted one of the first additive manufactured mega bone replacements in 2011. \n\nAshley Stratton-Powell\, Senior Medical Device Specialist\, MHRA\nAshley is Technical Lead for Orthopaedics at Medicines and Healthcare products Regulatory Agency (MHRA). He leads a team of Medical Device Specialists who are responsible for investigating trends in adverse incident reports\, issuing patient safety alerts and producing guidance on regulatory issues. He has a PhD in Medical Engineering from the University of Leeds and is a Chartered Engineer with the Institution of Mechanical Engineers.
URL:https://staging.medilinkmidlands.com/event/additive-manufacturing-3d-printing-special-interest-group-sig/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Ruth-Goodridge.jpeg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201008T103000
DTEND;TZID=Europe/London:20201008T113000
DTSTAMP:20260410T114231
CREATED:20200921T111505Z
LAST-MODIFIED:20200921T111505Z
UID:18368-1602153000-1602156600@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:Join EMAHSN for a virtual coffee break on Thursday 8 October at 10.30am. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis still restricts face to face events\, this online opportunity enables the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity to share your current challenges and experiences and find out how the EMAHSN can help. \nThe theme for this virtual coffee break will be Patient Public Involvement (PPI)\, Shahnaz Aziz\, PPI and Inclusion Lead from the EMAHSN will be attending to explain the importance of PPI\, how do do it well and the offers the AHSN have to support companies in this activity.  \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nChair and Panel details: \n Nick Brown\, Commercial Manager\, EMAHSN \n  \n  \n  \n  \nShahnaz Aziz\, PPI and Inclusion Lead\, EMAHSN \n  \n  \n  \n  \n Aisha Ajij\, Project Support and Industry Liaison Officer\, EMAHSN
URL:https://staging.medilinkmidlands.com/event/11088/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Shahnaz-Aziz.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T113000
DTSTAMP:20260410T114231
CREATED:20200327T100140Z
LAST-MODIFIED:20200327T100140Z
UID:18108-1601546400-1601551800@staging.medilinkmidlands.com
SUMMARY:Webinar: Commercial Applications for Next Generation Biomaterials
DESCRIPTION:This webinar with the University of Nottingham will look at Commercial Applications for Next Generation Biomaterials. \nThe biomaterials discovery programme at the University of Nottingham has been targeting novel polymers with application as coatings for existing medical devices to reduce infection rates and controlling foreign body reaction\, cell culture consumables for expansion and differentiation of stem cells\, particulates for targeting therapeutic delivery for cancer and infections and surfaces to control viral\, fungal and bacterial attachment in a wide variety of industries. They are looking for industrial organisations to partner with in the exploitation of these materials. \nPresentations will include: \n– Controlling bacterial biofilms formation using polymers \n– Controlling foreign body reaction to medical implants using coatings \n– New materials for breast cancer therapies \n– Technologies to control Fibrosis \nThere will be a Q&A session during the webinar. We have also created a facility post event (11.30am – 12.00pm) for you to join the presenters in a Microsoft Teams meeting to ask further questions directly to the presenters. Details of this meeting will be shared during the webinar. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nThe Biomaterials Discovery project at the University of Nottingham has funding available to partner with industrial partners that are keen to explore its emerging novel biomaterials and their potential in healthcare in short proof of concept studies. They encourage any companies that can see application of these technologies in their area to contact the panellists in the discussion session or send us an email. Please click here to contact the team. \n  \nSPEAKER PROFILES: \n \nProfessor Morgan Alexander\, Professor of Biomedical Surfaces\, University of Nottingham \nMorgan Alexander is Professor of Biomedical Surfaces\, the Director of the EPSRC Programme Grant in Next Generation Biomaterials Discovery and a Wellcome Trust Senior Investigator based in the School of Pharmacy at the University of Nottingham. He received his BSc in Materials (1988) and his PhD from the same department at The University of Sheffield in 1992. \nHis work involves developing materials for application in human healthcare and characterising relationships between surface structure and biological properties. Understanding these relationships is critical to the development of next generation biomaterials and it is the theme running through his group’s work across a variety of areas spanning control of bacterial adhesion\, to engineering cell response with applications in medical devices and cell manufacture. \n \nKiril Kalenderski\, PhD Student\, University of Nottingham \nKiril is a researcher at the University of Nottingham\, studying biofilm formation on bio-material surfaces developed as medical device coatings. He has predominantly worked with indwelling urinary catheters\, to determine the efficacy of bio-material coatings in reducing biofilm formation on these devices\, within in vitro experiments and clinical settings. \n  \n  \nDr Robert Cavanagh\, Research Fellow\, University of Nottingham \nRob completed his PhD in Drug delivery in 2017 at the University of Nottingham and focused on investigating intestinal permeability enhancers for the delivery of biologics. He joined Professor Cameron Alexander’s group in December 2017 as a post-doctoral researcher studying chemotherapeutic delivery using novel polymeric nanoparticles. \n  \n  \nDr Patrícia Monteiro\, Research Fellow\, University of Nottingham \nPatrícia received a B.Sc. and M.Sc. in Pharmacy and Pharmaceutical Sciences from the Federal University of Ouro Preto (UFOP)\, Brazil. In 2019 she completed her Ph.D. in drug delivery at the University of Nottingham. She then joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher. Her current research is focused on the development of bioresponsive polymers for triple negative breast cancer therapy. \n  \n  \n  \nDr Leanne Fisher\, Research Fellow\, University of Nottingham \nSchool of Life Sciences\, Immunology and Immuno-bioengineering Group \nLeanne’s research has focussed on the design and development of antimicrobial/anti-fouling surfaces to prevent the formation of biofilms on medical devices. More recently\, she has been studying the impact of surface engineering on immune modulation and prevention of the foreign body response. Alongside this\, Leanne works in developing immune-competent biomimetic tissue models\, specifically organ-on-a-chip models. \n  \n \nDr Matthew Vassey\, Research Fellow\, University of Nottingham \nMatthew received a B.Sc. in Microbiology and Cellular Biology in 2005 at the University of Nottingham. In 2014 he completed his Ph.D. in Cellular Microbiology also at the University of Nottingham. He joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher in November 2017. His current research is focused on cell biology\, human iPSC derived cells\, 3D biology\, host-pathogen interactions and infection biology. \n  \n  \n \nArsalan Latif\, PhD Student\, University of Nottingham \nArsalan is a final year doctoral student researching in developing stromal instructive niches to promote healing and suppress fibrosis\, at the University of Nottingham. Before which he did his master’s in biomedical engineering at Chalmers University of Technology\, Sweden. Besides science\, he enjoys building Lego models in his spare time. \n 
URL:https://staging.medilinkmidlands.com/event/commercial-applications-for-next-generation-biomaterials/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Morgan-Alexander.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200930T110000
DTEND;TZID=Europe/London:20200930T120000
DTSTAMP:20260410T114231
CREATED:20200902T133927Z
LAST-MODIFIED:20200902T133927Z
UID:18346-1601463600-1601467200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Clinical Trial - Design or Disaster?
DESCRIPTION:Join this ‘Clinical Trial – Design or Disaster?’ webinar to hear from Afortori Development and Simplified Data. This one hour webinar will explore: \n– Why is diligent and robust trial design needed?\n– What does it need to prove?\n– How complex does it need to be?\n– What kind of analysis needs to be undertaken? \nAttend to learn about the above and take the opportunity to get your questions answered by the experts. \nDURATION: 1 hour \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nDanielle Bodicoat\, Medical Statistics & Writing Consultant\, Simplified Data\nDanielle has over 12 years of experience as a medical statistician and writer with extensive experience of designing\, conducting and analysing clinical trials. She began her career researching the causes of breast cancer at the Institute of Cancer Research (University of London). She then went on to be a researcher and lecturer at the University of Leicester\, with a focus on diabetes. After a period working at Walgreens Boots Alliance to gain industry experience\, Danielle set up Simplified Data in 2019.  Danielle has a wealth of research\, statistics and writing experience. Danielle has particular expertise in diabetes and cardiovascular disease trials. Danielle has a PhD in Epidemiology\, MSc in Medical Statistics (Distinction) and BSc in Mathematics with Statistics (1st Class). \nNicola Wall \, along with Elizabeth Ralph founded Afortiori Development after long careers in clinical research within a variety of roles. Both bring a commitment to well designed and successfully executed clinical trials. \n\nDr Nicola Wall\, Chief Executive Officer\, Afortori Development  \n\nElizabeth Ralph\, Chief Operating Officer\, Afortori Development \n\nCharlotte Culver\, Clinical Project Leader\, Afortori Development\nCharlotte has a strong project management background in clinical research Phases I-V while delivering both commercial and non-commercial research throughout her career to produce quality results.\nShe is experienced in both pharmaceutical and device trials across several disease areas throughout the lifecycle of the project\, in collaboration with key pharmaceutical and device companies in the industry.\nHer proven project management track record provides her with the tools to deliver excellence and detailed delivery in clinical\, regulatory\, and financial aspects of clinical research.\nThroughout her research career\, she has worked on projects internationally\, as either multicentered or single-centre as lead. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-clinical-trial-design-or-disaster/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Danielle-Bodicoat.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200924T103000
DTEND;TZID=Europe/London:20200924T120000
DTSTAMP:20260410T114231
CREATED:20200819T071659Z
LAST-MODIFIED:20200819T071659Z
UID:18317-1600943400-1600948800@staging.medilinkmidlands.com
SUMMARY:WEBINAR: AI and Smart-Tech in the Home
DESCRIPTION:This webinar will explore AI and Smart-Tech in the Home\, take the opportunity to hear from Research Associates and Industry on this topic.  This event is in partnership with The Open University Faculty of Wellbeing\, Education and Language Studies. \nThe presenters will cover: \n– The MK:Smart programme\, a smart city initiative update and future directions for the smart city using the example of a hypothetical smart project using robots to encourage people to engage in active travel\, supporting healthy ageing and reducing social isolation \n– Hear from Pantri\, a company who embed AI into home appliances \n– Home assistance robots \n– A brief historical overview of robotic assistants plus overview of ‘Gatekeeper’ project including details on the application and it’s functionalities \nDURATION: 1.5 hours \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nGaynor Henry-Edwards\, Research Manager\, Faculty of Wellbeing\, Education and Language Studies – The Open University \nGaynor manages the Health and Wellbeing Strategic Research Area at The Open University. The Strategic Research Area supports\, coordinates and promotes health and wellbeing research across the university. Open University researchers conduct research in health and wellbeing across various disciplines and areas including healthcare management\, ageing studies\, reproductive and sexual rights\, assistive technologies\, patient data management\, mental health and biological health sciences. The scope of University expertise ranges from the science underpinning health and disease through to the medical humanities. The Open University is committed to working towards social justice specialising in participative and inclusive research methods with marginalised and vulnerable communities. \n\nMiguel Valdez\, Lecturer in Technology and Innovation Management\, School of Engineering and Innovation – The Open University\nMiguel began his career as a software engineer\, went on to become a technology journalist and is currently working as a Research Associate in the School of Engineering and Innovation at the Open University. His doctoral research interrogated sustainable transport pilots in Milton Keynes\, with a particular focus on the sensemaking activities that took place in organisations. He further developed this understanding of cities as experimental spaces within the transport work package of MK:Smart\, a £16 million smart city programme. Through his research\, Miguel has explored the role of innovative technologies in envisioned and developing future urban environments. His research has drawn insights from urban geography and innovation studies to interrogate how the experimental spaces in cities may facilitate the development of new knowledge about sustainable innovation\, and on how such knowledge coalesce and travel. \n\nTom Cooper\, CEO\, Pantri\nTom is the CEO and founder of Pantri – a new platform which aims to make the new breed of WiFi connected kitchen appliances shop for repeat purchases automatically.  He is considered a thought leader in the smart kitchen industry\, with regular appearances in industry publications where he shares his views on how over the next 10 years\, a lot of the weekly shop is going to become a lot easier and automated thanks to exciting new IoT and AI breakthroughs. \n\nGianluca Bardaro\, Research Associate\, Knowledge Media Institute – The Open University \nGianluca’s area of research is robotic software development. In particular\, he is interested in how to enhance the existing tools and approaches to streamline the development process and achieve more complex\, robust and functionality-rich robot applications. Currently\, he is involved in the GATEKEEPER European project\, as a task leader. As part of this project\, his aim is developing a robotic assistant which operates within a smart home environment and which is capable of addressing the healthcare needs of elderly people.
URL:https://staging.medilinkmidlands.com/event/webinar-ai-and-smart-tech-in-the-home/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/GaynorHenryEdwards_OU.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200923T110000
DTEND;TZID=Europe/London:20200923T120000
DTSTAMP:20260410T114231
CREATED:20200212T133227Z
LAST-MODIFIED:20200212T133227Z
UID:18064-1600858800-1600862400@staging.medilinkmidlands.com
SUMMARY:Webinar: Precision Imaging- transforming healthcare and nutrition with pioneering imaging
DESCRIPTION:Join this webinar with the University of Nottingham where they will showcase the latest developments and capabilities in precision imaging. \nTopics will include innovations in the application of imaging tools to:\n-Pharmaceuticals\n-Nutrition in food and beverages\n-Medical Devices\n-Biomarkers for health \nThere will also be an opportunity to ask your questions directly to the presenters in a Q&A session. \nA wide range of available expertise will be explored from medicine\, physics\, mathematics\, psychology\, life sciences and computer sciences. Information will also be presented on the facilities dedicated to research full time\, so you can find facilities and expertise to help with your product development. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \nProfessor Dorothee Auer\, Professor of Neuroimaging\, MD\, PhD  \nDirector\, Precision Imaging Beacon of Excellence\, Imaging Theme Lead\, NIHR ~Nottingham BRC \nDorothee’s research interest is to develop imaging biomarkers in Clinical Neurosciences using advanced MRI techniques. Aims are: (1)understand the pathophysiology of diseases/complex symptoms across diseases\, (2)improve diagnostic accuracy\, (3)predict and assess therapeutic interventions. Methods include MR proton spectroscopy\, diffusion tensor imaging\, perfusion\, relaxometry\, high resolution carotid imaging and combined electrophysiological/fMRI. \nProfessor Luca Marciani\, Precision Imaging Beacon\, Industrial Strategy and Business Engagement Lead\, University of Nottingham \nLuca’s expertise is in imaging the human gastrointestinal (GI) tract using MRI. His research focuses on GI physiology/pathology using MRI combined with other techniques. Luca is interested in in-body imaging of foods\, beverages\, dosage forms and formulations\, intestinal fluid distribution and developing novel MRI tests for GI motility and transit. \n  \n 
URL:https://staging.medilinkmidlands.com/event/precision-imaging-transforming-healthcare-and-nutrition-with-pioneering-imaging/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Dorothee-Auer.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200922T103000
DTEND;TZID=Europe/London:20200922T113000
DTSTAMP:20260410T114231
CREATED:20200818T151840Z
LAST-MODIFIED:20200818T151840Z
UID:18333-1600770600-1600774200@staging.medilinkmidlands.com
SUMMARY:Webinar: Is your Business Case NHS Ready?
DESCRIPTION:Join the second of our two-part CPD accredited virtual workshops\, Is your Business Case NHS Ready?\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nThe challenge as innovators and companies selling to the NHS is often that when you have a product that improves patient outcomes and saves cost you still cannot get it adopted by the NHS. This is frequently because there isn’t a fully developed business case. \nPART 1 is a pre-recorded 40 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– What a business case is\, what is its purpose and why is it so important? \n– Who reviews the business case and how are they evaluated? \n– How to construct a good business case \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Tuesday 22nd September. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE: \n Nicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://staging.medilinkmidlands.com/event/webinar-is-your-business-case-nhs-ready/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200917T103000
DTEND;TZID=Europe/London:20200917T120000
DTSTAMP:20260410T114231
CREATED:20200806T073511Z
LAST-MODIFIED:20200806T073511Z
UID:18304-1600338600-1600344000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Infectious Diseases Special Interest Group (SIG) - Infection Control during COVID-19: Masks\, hands and surfaces
DESCRIPTION:The next Infectious Diseases Special Interest Group will take place online and the focus will be on Infection Control during COVID-19: Masks\, hands and surfaces. \nThis event is in partnership with De Montfort University and led by Dr Katie Laird\, Reader in Microbiology and also Head of the Infectious Disease Research Group at De Montfort University. Presentations will be given on: \n– Masking the masses: Efficacy and controversies of face masks\n– Surface Disinfection\, hand sanitation and COVID-19.  What have we done\, and what should we have done?\n– Supporting the NHS during COVID-19 \nDURATION: 1.5 hours \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n\nDr Katie Laird\, Head of the Infectious Disease Research Group at Leicester School of Pharmacy\, De Montfort University \nKatie has a BSc (Hons) in Biology and obtained a PhD in applied microbiology in 2008. During her PhD she developed and patented an essential oil based antimicrobial vapour\, whilst her postdoctoral work included the assessment of natural antimicrobials efficacy against post-harvest pathogens.\nHer research interests include the use of natural products as antimicrobials in particular to combat hospital acquired infections and biofilms.  Her other area of research includes the assessment of healthcare laundry as a potential route of cross contamination in the clinical arena. \n \nDr Maitreyi Shivkumar\, Lecturer in Molecular Biology at Leicester School of Pharmacy\, De Montfort University\nMaitreyi is a virologist and lecturer in De Montfort University. Her research has focussed on host-pathogen interactions in the context of entry and transmission of viruses. She has recently established her lab at the Leicester School of Pharmacy\, where she is working on developing broad-spectrum antivirals as well as investigating infection control strategies against coronaviruses. \n\nDr Andrew Kemp\, Principal Scientific Officer\, Q Technologies\nAndrew holds a PhD in surface disinfection and decontamination. His specialist area of research is testing for bio burden\, long term disinfection and decontamination. Dr Kemp consults for BICSc\, governments\, private organisations and companies. He is regarded as a global expert in his specialist area of work\, undertaking research at the University of Lincoln and the University of Baltimore. He is a member of the steering group for the UK Infectious Diseases Research group. He recently completed writing the environmental cleaning and disinfection guide and standards for the UK NHS Improvement organisation. \n\nLinda Knight\, Training Specialist\, Pal International\nLinda has worked in medical consumables for over 25 years as a business development manger and specialist trainer primarily in the infection prevention sphere. Linda currently works for Pal International in the MediPal division. She has a keen interest in cooking having trained as a chef and loves to spend time with her grandchildren.
URL:https://staging.medilinkmidlands.com/event/webinar-infectious-diseases-special-interest-group-sig-infection-control-during-covid-19-masks-hands-and-surfaces/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Katie-Laird.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200910T103000
DTEND;TZID=Europe/London:20200910T113000
DTSTAMP:20260410T114231
CREATED:20200818T144321Z
LAST-MODIFIED:20200818T144321Z
UID:18332-1599733800-1599737400@staging.medilinkmidlands.com
SUMMARY:Webinar: Introduction to NHS Market Access
DESCRIPTION:REGISTRATION FOR THIS SESSION IS NOW CLOSED. The next date for this webinar is Wednesday 21st October. To register\, please click here. \nJoin our two-part CPD accredited virtual workshop\, Introduction to NHS Market Access\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nCombined\, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS. \nPART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– The NHS Structure \n– Understanding pathways and cash flow \n– Getting your message right \n– What support you can expect from the AHSN \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Thursday 10th September. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \nThis free to attend virtual event will be held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £222\, but is delivered completely free of charge to participants. \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE: \nNicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://staging.medilinkmidlands.com/event/introduction-to-nhs-market-access-3/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200908T110000
DTEND;TZID=Europe/London:20200908T120000
DTSTAMP:20260410T114231
CREATED:20200817T082646Z
LAST-MODIFIED:20200817T082646Z
UID:18327-1599562800-1599566400@staging.medilinkmidlands.com
SUMMARY:Webinar: How does the demise of the Privacy Shield impact Life Sciences businesses?
DESCRIPTION:[box type=”shadow” align=”” class=”” width=””]We have unfortunately had to postpone this webinar. We sincerely apologise for this inconvenience and will update our website with further information of a new date as soon as this becomes available. If you have any questions\, please email us at info@medilinkem.com\, or call us on 0115 822 3154. [/box] \nAt the end of July\, the European Court of Justice struck down the US Privacy Shield\, and although it focused on EU-US data transfers\, the ruling is already causing widespread aftershocks for international personal data transfers within the EEA. International group companies using personal data\, or even non-international organisations which are using Cloud or other service providers in non-EEA countries (such as India or elsewhere)\, need to be aware of the implications arising from the ruling. \nFor life sciences businesses\, the kinds of data that may be affected could be data about individual patients and their treatment\, clinical trial data and information about staff\, research colleagues and physicians. Organisations have become so used to working digitally that they may not even fully appreciate when international data transfers are taking place. \nJagvinder Singh Kang\, International and UK Head of IT at Mills & Reeve considers what steps you can take to protect your organisation following the ruling. \nThis webinar will be relevant to all organisations involved in international personal data transfers from within the EEA\, whether to group companies\, service providers or other organisations. \nThere will also be an opportunity to ask the presenters questions\, when Jagvinder will be joined by for a Q&A session byspecialist Life Sciences Lawyer Stephanie Caird. \nDURATION: 1 hour \nPlease note that due to privacy restrictions this webinar will NOT be recorded and the presentation slide will not be available to download. \nThis free to attend webinar will be held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund. For further details please click here. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSPEAKER PROFILES: \n Jagvinder Singh Kang – International and UK Head of IT (CIPP/E\, CIPM) \nJagvinder is a market leading technology lawyer. He is featured in Legal 500’s official ‘Hall of Fame’ – which Legal 500 confirms: “highlights\, to clients\, the law firm partners who are at the pinnacle of the profession.” He has been recognised for 9 consecutive years in Legal 500’s ‘Elite List of Outstanding Technology Lawyers Nationwide’\, and consistently been ranked number one for IT and technology law by Legal 500 and Chambers & Partners for the same period. Jagvinder is a specialist technology and GDPR/data protection lawyer (CIPP/E\, CIPM)\, as well as a qualified software engineer (First Class BSc (Hons) Computer Science & Software Engineering) and he has completed the academic requirements for Chartered Engineer status as well. Furthermore\, he has over 20 years of technology law expertise from having advised on billions of pounds worth of UK and international technology transactions\, involving FTSE 100\, NASDAQ listed and other world-class corporates. He has also undertaken global\, European and UK GDPR compliance projects. \n  \n \nStephanie Caird – Commercial Lawyer \nStephanie is a lawyer in the life sciences practice\, with significant experience in data protection\, intellectual property\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors. Stephanie has worked in-house in various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaborations and Brexit related intra-group arrangements.
URL:https://staging.medilinkmidlands.com/event/webinar-how-does-the-demise-of-the-privacy-shield-impact-life-sciences-businesses/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Jagvinder-Singh-Kang-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200820T103000
DTEND;TZID=Europe/London:20200820T113000
DTSTAMP:20260410T114231
CREATED:20200722T072032Z
LAST-MODIFIED:20200722T072032Z
UID:18289-1597919400-1597923000@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:A chance to hear more about the East Midlands Academic Health Science Network Digital Health Accelerator and how to apply for the next cohort. \nJoin EMAHSN for a virtual coffee break on Thursday 20 August at 10.30am. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis won’t allow face to face events\, we have introduced this online opportunity to enable the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity find out how the EMAHSN can help innovators through the Digital Health Accelerator. \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nChair Details: \n \n  \nNick Brown\, Commercial Manager\, EMAHSN
URL:https://staging.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-3/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200819T103000
DTEND;TZID=Europe/London:20200819T113000
DTSTAMP:20260410T114231
CREATED:20200709T153253Z
LAST-MODIFIED:20200709T153253Z
UID:18281-1597833000-1597836600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Grant Application Writing Masterclass
DESCRIPTION:Join TBAT Innovation Ltd for a Grant Funding Masterclass\, delving into how to write a successful grant application for Innovate UK. \nKnowing how to write your grant funding application is the most important part of applying for innovation funding. \nMany competitions have success rates of below 10%; therefore\, your application needs to stand-out\, showcase your innovation and demonstrate your knowledge and expertise\, all within tight word-limits. \nThrough years of successfully helping businesses just like yours\, apply for Innovate UK funding competitions\, TBAT are experts in writing successful funding applications that will capture the assessor’s attention and highlight why your innovative project should be funded! \nDuring this 1-hour masterclass\, TBAT will cover:\n– The 10-question application form\n– How to answer each question\n– Their top tips for applying for Innovate UK funding\n– What to do if you need help applying \nThis is great opportunity to learn how to apply for current Innovate UK funding competitions such as the August round of Smart Grants and the Bio-Medical Catalyst and secure up to 70% of your project costs via these opportunities. \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: this webinar is close to reaching the maximum number of delegates permitted\, if you are unable to book on the link below\, please email info@medilinkem.com requesting to be added to the waiting list. \nSpeaker Profiles: \nMatt Symonds\, Managing Director\, TBAT Innovation Ltd \nMatt Symonds joined TBAT Innovation in 2007 and shortly after became a Director of the business. He has a mechanical engineering degree and is an experienced project manager as a result of ten years’ experience in the Aerospace\, Power Generation and Rail sectors with companies like Rolls-Royce and Bombardier Transportation. \n  \n  \n Vincent Seddon\, Business Development\, TBAT Innovation Ltd \nVincent Seddon joined TBAT in 2019 to head up Business Development for their Oxford office after spending 10 years supporting Corporate clients to plan and grow their businesses as well as mentoring and coaching local business managers with the Barclays Business Bank.
URL:https://staging.medilinkmidlands.com/event/webinar-grant-application-writing-masterclass/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Vincent-Seddon.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200813T110000
DTEND;TZID=Europe/London:20200813T120000
DTSTAMP:20260410T114231
CREATED:20200728T073330Z
LAST-MODIFIED:20200728T073330Z
UID:18298-1597316400-1597320000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The COVID-19 catalyst - how the pandemic has optimised the opportunity for digital health
DESCRIPTION:Join Medilink East Midlands and Spirit Health Group to see how the COVID-19 pandemic has optimised the opportunity for digital health. \nAlthough the virus has been devastating for so many\, it has also accelerated development and adoption of technology across many areas of the healthcare system. \nIn this webinar\, Simon and Nadine will openly discuss the ups and downs of being at the forefront of remote healthcare delivery in Leicestershire. They will share insights about: \n– Working with the NHS during lockdown\n– How patients respond to change\n– The challenge of doing all this without ever having met face to face! \nDURATION: 1 hour \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n\nSimon Applebaum\, Managing Director\, Spirit Digital\nSimon is the Managing Director of Spirit Digital. He joined Spirit Health Group early in 2020 after 15 years of working in digital transformation in the travel and leisure industry and is passionate about the opportunity to transform and improve patient pathways through the use of technology. \n\nNadine Miles\, Director of Market Development\, Spirit Health Group\nNadine is Director of Market Development at the 10 year old healthcare company Spirit Health Group. Having graduated from Birmingham with a Business Studies degree and two post-graduate marketing qualifications\, she worked in banking\, retail\, and postal services before joining the NHS 19 years ago. With NHS roles within primary care\, secondary care\, mental health trusts and in the (now defunct) Strategic Health Authority\, she’s now in the independent sector focusing on making health easy for patients and clinicians within the NHS system.
URL:https://staging.medilinkmidlands.com/event/webinar-the-covid-19-catalyst-how-the-pandemic-has-optimised-the-opportunity-for-digital-health/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Simon-Applebaum.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200806T110000
DTEND;TZID=Europe/London:20200806T120000
DTSTAMP:20260410T114231
CREATED:20200721T141759Z
LAST-MODIFIED:20200721T141759Z
UID:18285-1596711600-1596715200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The EU MDR Deadline Extension\, where are we now?
DESCRIPTION:This short webinar will explain what the latest timescales are\, and what changes have been made to the MDR since it was first published. Peter Rose\, Director of PRQR Ltd will go through the main points of change and provide practical advice on what to do in preparation for going live next year. The extension should not be seen as time for a break but more as time to get things right for a smooth and trouble free transition with no interruption to supply of your products to the EU market. The webinar will also briefly discuss Brexit and what we might expect from the new Medicines and Medical Devices Bill. \n– New deadline date\n– The Changes – 2 corrigenda\, a formal M1 revision including significant changes for Class I Devices\n– Notified Body Capacity – Act Now!\n– The B word (Brexit)\n– The new Medicines and Medical Devices Bill including the Cumberlege Review\n– Resources \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profile:\n\nPeter Rose\, Director\, PRQR Ltd\nPeter is the founder and principal consultant of PRQR Ltd. With over 26 years of experience working in the field of Medical Devices and In Vitro Diagnostics\, Peter has expertise covering Quality Assurance\, Regulatory Affairs\, Sterilisation\, Cleanrooms and Contamination Control. \nPeter is a qualified Microbiologist\, a Chartered biologist\, Member of the Royal Society of Biology\, Practitioner Member of the Chartered Quality Institute and a Member of TOPRA. Peter has an abundance of experience and expertise in Quality\, Regulatory and microbiological matters for Medical Devices and IVDs across the UK and Europe. \nPeter possesses a range of technical and business skills that enable him to provide unique insight to new and emerging businesses. He takes a hands-on approach to challenges and is adept at creative problem-solving. As a highly driven and entrepreneurial business leader\, Peter has extensive senior leadership and board-level experience. As a well-regarded voice within the industry\, Peters holds the position of Director within Medilink East Midlands\, sits on a variety of industry committees and working groups and has been invited to address the European Parliament and Government ministers. \nPeter’s extensive experience includes the new Medical Device Regulation\, the new IVD Regulation the three established Medical Device Directives. He also has expertise in quality management systems covering ISO 9001\, ISO 13485 and 21 CFR 820 (QSR).
URL:https://staging.medilinkmidlands.com/event/webinar-the-eu-mdr-deadline-extension-where-are-we-now/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Peter-Rose-New-PRQR.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200729T140000
DTEND;TZID=Europe/London:20200729T150000
DTSTAMP:20260410T114231
CREATED:20200518T115538Z
LAST-MODIFIED:20200518T115538Z
UID:18280-1596031200-1596034800@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:A chance to meet other businesses\, share ideas and hear what’s happening from the East Midlands Academic Health Science Network Team. \nJoin EMAHSN for a virtual coffee break on Wednesday 29 July at 2pm. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis won’t allow face to face events\, we have introduced this online opportunity to enable the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity to share your current challenges and experiences and find out how the EMAHSN can help. \nAt this coffee break we will be joined by Dr Ayokunmi Ajetunmobi\, Venture Development Manager from BioCity Group\, join to find out about the BioCity Accelerator Programmes.  The programme is specifically for life science entrepreneurs\, based upon the Lean- Start Up approach and evidence-based entrepreneurialism.  Not just for start-ups and spin-offs\, the BioCity Business Accelerator Programme works with entrepreneurs at every stage from idea to exit to help businesses to get off the ground\, and continue to grow\, entrepreneurially. \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \n\nChair and guest details: \n \n  \nNick Brown\, Commercial Manager\, EMAHSN \n  \n  \n  \nDr Ayokunmi Ajetunmobi\, Venture Development Manager\, BioCity Group
URL:https://staging.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-2-2/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Events-1.png
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200728T110000
DTEND;TZID=Europe/London:20200728T120000
DTSTAMP:20260410T114231
CREATED:20200626T151023Z
LAST-MODIFIED:20200626T151023Z
UID:18262-1595934000-1595937600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Planning and Conducting an Effective Clinical Trial
DESCRIPTION:Join Afortiori Development Ltd for a practical insight into clinical trials. The webinar will explore: \n• What is a trial?\n• Why do we need a trial?\n• What is a good trial?\n• What exactly is involved in running a trial? \nJoin us to hear about the important considerations and common pitfalls as well as gain a good understanding of the tasks and responsibilities involved for Sponsors. There will be ample opportunity to ask questions and benefit from the wide ranging experience of the presenters. \nThis free to attend meeting will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \nNicola Wall \, along with Elizabeth Ralph founded Afortiori Development after long careers in clinical research within a variety of roles. Both bring a commitment to well designed and successfully executed clinical trials. \n \nDr Nicola Wall\, Chief Executive Officer\, Afortiori Development \n \nCharlotte Culver\, Clinical Project Leader\, Afortiori Development
URL:https://staging.medilinkmidlands.com/event/webinar-planning-and-conducting-an-effective-clinical-trial/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Nicola-Wall-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200722T110000
DTEND;TZID=Europe/London:20200722T120000
DTSTAMP:20260410T114231
CREATED:20200624T132813Z
LAST-MODIFIED:20200624T132813Z
UID:18233-1595415600-1595419200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: How the NIHR can support your route to market
DESCRIPTION:The National Institute for Health Research (NIHR) Clinical Research Network (CRN) works in partnership with the NHS to deliver high quality research. Join this webinar to gain an understanding of how the NIHR can support your route to market. \nHosted by the NIHR/CRN\, they will cover: \n– The role of the NIHR/CRN \n– What NIHR can currently offer to companies; Clinical Engagement\, Research Funding\, Access to the NHS \n– Plans for future support/priority areas \n– How companies should approach NIHR \n– What can Medilink EM and the Academic Health Science Network do to help \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nDaniel Kumar\, Industry Operations Manager\, CRN: East Midlands\nDan has a degree in Business Management Studies and worked for an accountancy firm prior to moving into the NHS in 1996. Currently with over 20 years NHS experience\, as a nurse across Malignant Haematology\, High Dependency and Coronary Care\, Research Nurse\, Manager of a Cancer Research Team and then Senior Manager within Research Governance. Dan led on Industry for Trent CLRN since 2011 prior to this post.\nAs part of the CRNEM leadership team this current role focuses on the development of the commercial research portfolio across all stages of the study lifecycle. This involves a particular focus on recruitment of trials to targets and growth of the sector\, working along with SMEs and Medical Technology. \n\nTheo Christie\, Business Development Manager (Commercial)\, CRN National Coordinating Centre\nTheo facilitates key discussions between the life sciences industry and the Clinical Research Network and is a point of contact for the life sciences companies engaging with the Clinical Research Network. Theo is able to provide advice to companies on how they are able to tap into the Clinical Research Network study support services to ensure clinical studies are set up efficiently and recruit to time and target.\nWith a degree in Clinical Sciences\, Theo has been with the Clinical Research Network since 2013. Before joining the Business Development and Marketing Team\, Theo previously worked within the organisation’s Research Delivery Directorate where he was responsible for supporting interactions between the life sciences industry across 10 therapeutic areas\, providing operational support through feasibility\, set up and patient recruitment. \n\nRoz Sorrie-Rae\, Lead Research Management & Governance Manager\, Leicestershire\, Northamptonshire & Rutland Comprehensive Local Research Network\nRoz has worked in the NHS for over 28 years in the fields of clinical audit and effectiveness\, clinical governance and research. She joined her current role in 2008 and continued in that role when CRN East Midlands was established. From late 2014\, she spent a year in Nova Scotia\, Canada\, and gained an international perspective on health research\, having spent her time abroad working in R&D in the Canadian university sector. On her return to the UK\, she commenced in the role of HRA Approval Business Lead with the National CRN Coordinating Centre. Alongside this national role\, she returned to CRN East Midlands in a senior Research Management & Governance Manager capacity. In November 2016\, she took up the role of CRN East Midlands Study Support Service Operations Manager and has in 2020 moved into a Study Support Service Compliance and Assurance Manager role. During her career\, Roz has co-authored numerous papers and publications\, both as a researcher and subject matter expert\, including a chapter on Budget and Funding in An Introduction to Health Services Research (2014; Sage).
URL:https://staging.medilinkmidlands.com/event/webinar-how-the-nihr-can-support-your-route-to-market/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/dan-kumar-new-1.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200716T100000
DTEND;TZID=Europe/London:20200716T113000
DTSTAMP:20260410T114231
CREATED:20200325T135017Z
LAST-MODIFIED:20200325T135017Z
UID:18094-1594893600-1594899000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Medical Technologies & Systems Special Interest Group (SIG)
DESCRIPTION:The next Medical Technologies & Systems Special Interest Group (SIG) will take place online\, join us as we discuss Digital Health: Current Applications and Future Trends for Mental Healthcare. \nTalks at this webinar will include: \n– The impact of COVID-19 on Mental Health \n– Evaluating new technologies for mental health \n– Deriving Clinical Outcome Measures from Expression and Speech for use as Clinical Trial Endpoints: Results of a Proof of Concept Study \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n\nProfessor Philip Breedon\, Professor of Smart Technologies\, Nottingham Trent University \nAs well as his role at Nottingham Trent University\, Philip is also a Chartered Engineer and a Chartered IT professional. He is a member of the Department of Health’s National Institute for Health Research invention for innovation funding panel and holds a number of journal editorial positions. His research interests and latest projects centre on new and emerging technologies and materials. This includes wearable technologies\, 3D printing of pathological models\, additive and subtractive manufacturing for medical applications\, surgical robotics\, cardiovascular devices\, augmented /virtual/immersive technologies and environments\, the surgical pathway and investigative research related to the utilisation of ‘smart materials’ for medical applications. Through promoting his work and research activities he now works with a number of surgeons and clinicians across Europe. \n \nDr Louise Thomson\, Assistant Professor in Occupational Psychology and Practitioner Psychologist\, The University of Nottingham\nLouise is a Chartered Psychologist (CPsychol) and HCPC-registered Occupational Psychologist specialising in psychological\, social and organisational issues in occupational health and job retention. She is currently the Course Director for the MSc in Occupational Psychology at the University of Nottingham\, and Lead Academic for the Institute of Mental Health’s Research Support and Consultancy Service. Louise has extensive experience of working in the health and social care sector\, but has also worked with other public and private sector clients\, as well as the third sector. She has been an expert member of three NICE committees developing guidance on: return-to-work after long-term sickness absence; mental well-being at work; and workplace health quality standards. She currently leads the Well-being of the Workforce Study which is exploring the impact of COVID-19 on the mental health and well-being of the UK workforce. \n\nDr Michael Craven\, Senior Research Fellow\, The University of Nottingham\, Institute of Mental Health\nMike is an academic researcher in the NIHR MindTech MedTech Co-operative\, a national centre established in 2013 to focus on developing the evidence and methods needed to bring new technologies for mental health into the National Health Service. He is also a member of University of Nottingham Faculty of Engineering’s Bioengineering research group and the Institute of Mental Health’s Centre for Dementia\, holds an honorary contract with Nottinghamshire Healthcare NHS Foundation Trust and is Health Economist in the Nottingham University Hospitals’ Centre for Healthcare Equipment and Technology Adoption (CHEATA). In MindTech\, Mike contributes expertise in design and evaluation of digital health and medical device related interventions and assistive technologies. He has conducted health technology assessments and reviews for NHS organisations and industry and contributes to policy on digital mental health. Currently\, he is co-investigator on several of MindTech’s large collaborations and trials of technologies which include evaluation of cognitive training software\, remote/mobile mental health and virtual reality therapy\, and various co-design projects with patients and healthcare professionals. \n\nBill Byrom\, Vice President of Product Strategy and Innovation\, Signant Health\nBill leads product strategy and innovation\, and the electronic patient-reported outcomes (ePRO) Science team\, at Signant Health. He has worked in the Pharmaceutical industry for over 25 years and is the author of over 70 publications and two industry textbooks on ePRO. His recent scientific work includes the use of wearable technology and ePRO in clinical trials. Bill is an active member of the Critical Path Institute’s ePRO Consortium\, is a member of the scientific leadership board of the Digital Medicine Society\, and leads a cross-industry working group on wearable technology within the Drug Information Association’s Study Endpoints Community. Bill provides eClinical commentary on LinkedIn and Twitter (@billbyrom).
URL:https://staging.medilinkmidlands.com/event/medical-technologies-systems-special-interest-group-sig-4/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Philip-Breedon-3841-scaled.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200715T110000
DTEND;TZID=Europe/London:20200715T120000
DTSTAMP:20260410T114231
CREATED:20200615T125511Z
LAST-MODIFIED:20200615T125511Z
UID:18216-1594810800-1594814400@staging.medilinkmidlands.com
SUMMARY:WEBINAR: How to pitch to Investors as a Life Science Company
DESCRIPTION:This webinar introduces life science and healthcare SMES and innovators to some of the key factors to consider when approaching private investors for funding. \nAlongside speakers from BioCity and the East Midlands Academic Health Science Network\, the webinar will cover: \n-What investors are looking for \n-Why startups fail \n-Finding product-market fit \n-Telling the story \nPlus there will be the opportunity to ask questions directly to the presenters. \nDURATION: 1 hour \nSpeakers: \n \nAisha Ajij\, Project Support and Industry Liaison Officer\, East Midlands Academic Health Science Network \nAisha has worked at the East Midlands Academic Health Science Network (EMAHSN) since 2014. She has experience in working with innovators from industry\, NHS and academia. She works with companies helping them to navigate the NHS marketplace and provides advice\, support and signposting to help them to develop their offer. Aisha organises and supports a number of consultation sessions on behalf of the EMAHSN. She is passionate about making innovations more accessible for patients and clinicians. \n  \n  \n  \n Dr Ayokunmi Ajetunmobi\, Venture Development Manager\, BioCity Group \nHelps entrepreneurs build breakthrough life science and healthcare ventures. Currently leading venture development activities at BioCity Group. Provide scientific\, entrepreneurial\, and business development expertise for the creation of venture-backed companies solving global challenges in health and the environment. Previous experience in a venture-backed biotech startup enabling therapeutic applications of genome editing. \n  \n  \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/webinar-how-to-pitch-to-investors-as-a-life-science-company/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Ayokunmi-Ajetunmobi.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200714T140000
DTEND;TZID=Europe/London:20200714T150000
DTSTAMP:20260410T114231
CREATED:20200611T124941Z
LAST-MODIFIED:20200611T124941Z
UID:18209-1594735200-1594738800@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Food Supplements Special Interest Group (SIG) - a focus on Vitamin D
DESCRIPTION:Join us online for our next Food Supplements Special Interest Group (SIG) to hear about how Vitamin D continues to be a nutrient that dominates the media headlines\, whether due to nutritional deficiency\, national guidelines to supplement or as a panacea for good health.\nWe invite you to hear some of the facts around Vitamin D\, with our speaker Steve Simbler\, a pharmacist who has more than 20 years’ experience in medicines management in sport. Steve is the Head of the Sports Division at Synergy Biologics\, who have Pro D3 within their portfolio. Steve has a professional view to share about Vitamin D and its role in supplementation in all our lives. \n– Does vitamin D fall into the category of what we classically know as a vitamin?\n– What is the best form of vitamin D for us\, and how much and how often do we need it?\n– What is the best/safest way for us to obtain vitamin D?\n– What does it actually mean when we are vitamin D deficient/insufficient/sufficient\, and what can go wrong if our levels are low?\n– Is the attitude to vitamin D the same globally\, and in particular what are the UK recommendations?\n– What are the ramifications of recent government directives reducing NHS access to maintenance doses of vitamins?\n– Why are professional athletes often taking higher dosages of vitamin D? \nAs well as the opportunity to hear some facts about Vitamin D you can take part in a question and answer session. \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles \n\nSteve Simbler MRPharm.S\, Head of Sports Division\, Synergy Biologics \nSteve has been working as a pharmacist in elite sport for over 20 years\, initially in a supply capacity\, and for the past 10 years in providing medicines management consultancy and software to teams in the Premier League and English Football League as well as national governing bodies for football\, rugby\, athletics\, tennis\, cricket\, rowing\, and cycling amongst others.\nHe was one of the lead pharmacists for the London 2012 Olympics and Paralympics\, then again for the London 2017 Athletics and Para-Athletics World Championships.\nAs well as giving talks about vitamin D\, he lectures on various topics pertaining to drugs in sport and the use of analgesics and anti-inflammatories in sport.\nIn 2006\, sport doctors approached Steve to advise on obtaining a reliable source of vitamin D that could pass tests for WADA-prohibited substances\, this prompted an association with Synergy Biologics\, makers of Pro D3\, and this relationship is ongoing\, and stimulated an interest in vitamin D on which he keeps abreast of research\, and reads extensively.\nSince 2016 Steve has been a pharmacist panel member for the General Pharmaceutical Council’s Fitness to Practise Committee\, and has recently started as an NHS Test and Trace clinical contact tracer on a part time basis. \n\nJanet Worrell\, Head of Regulatory\, JensonR+\nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS.
URL:https://staging.medilinkmidlands.com/event/webinar-food-supplements-special-interest-group-sig/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Steve-Simbler-Image-small.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200709T110000
DTEND;TZID=Europe/London:20200709T120000
DTSTAMP:20260410T114231
CREATED:20200515T081236Z
LAST-MODIFIED:20200515T081236Z
UID:18171-1594292400-1594296000@staging.medilinkmidlands.com
SUMMARY:Webinar: Opportunities in Medtech Innovation: Long-term neurological conditions
DESCRIPTION:People living with long-term neurological conditions (e.g. MND\, MS\, Parkinson’s Disease) are reported to have the lowest health-related quality of life of any long-term condition\, with the numbers of people affected continuing to rise. \nAs society and healthcare systems respond and adapt to the impact of the COVID-19 pandemic\, this webinar is an opportunity for businesses to: \n• understand the key challenges affecting patients & the health and care system\,\n• learn about the market for technology solutions within new models of care & self-management\, &\n• connect with collaborative networks to catalyse & advance product innovation. \nOur speakers from NIHR Devices for Dignity will give you the opportunity to ask any questions you may have during the webinar. \nThis webinar is open to Life Science businesses who are seeking to learn about the opportunities in medtech innovation and wish to ask questions directly to the experts. \nThis free to attend meeting will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nProfessor Christopher McDermott\, Professor of Translational Neurology at Sheffield Institute for Translational Neuroscience (SiTRAN) at the University of Sheffield and Consultat Neurologist at Sheffield Teaching Hospitals NHS Foundation Trust\, – leading research programmes developing supportive interventions to improve care of individuals living with neurological conditions \n  \n  \n  \n \nPhilippa Hedley-Takhar\, Business Development Manager for NIHR Devices for Dignity Medtech Cooperative\, a national collaborative network catalysing technology development for chronic health conditions associated with loss of dignity and independence. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-opportunities-in-medtech-innovation-long-term-neurological-conditions/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Chris-McDermott.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200708T103000
DTEND;TZID=Europe/London:20200708T113000
DTSTAMP:20260410T114231
CREATED:20200518T115538Z
LAST-MODIFIED:20200518T115538Z
UID:18226-1594204200-1594207800@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:A chance to meet other businesses\, share ideas and hear what’s happening from the East Midlands Academic Health Science Network Team. \nJoin EMAHSN for a virtual coffee break on Wednesday 8 July at 10.30am. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis won’t allow face to face events\, we have introduced this online opportunity to enable the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity to share your current challenges and experiences and find out how the EMAHSN can help. \nThe theme for this coffee break is regulatory/CE marking & making sure you meet the standards and we will be joined by Dr Sarah Bolton\, Business Manager from CHEATA (The Centre for Healthcare Equipment & Technology Adoption). CHEATA offer a unique contract-based support service to clinical\, academic and commercial med-tech developers to gather evidence for NHS adoption and to help their clients develop devices that are truly NHS-ready. \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \n\nChair and guest details: \n \n  \nNick Brown\, Commercial Manager\, EMAHSN \n  \n  \n  \n Dr Sarah Bolton\, Business Manager\, CHEATA
URL:https://staging.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-2-2-2/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/gif:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Sarah-Boltonweb-1.gif
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200702T110000
DTEND;TZID=Europe/London:20200702T120000
DTSTAMP:20260410T114231
CREATED:20200619T074904Z
LAST-MODIFIED:20200619T074904Z
UID:18229-1593687600-1593691200@staging.medilinkmidlands.com
SUMMARY:Webinar: Business Re-organisation to Protect your assets and to manage staffing issues
DESCRIPTION:Join Shakespeare Martineau Partners\, Sean Moran and Rhys Wyborn\, for a discussion of important considerations around business re-organisations and protecting assets\, including staffing issues that may arise. \nSean will provide an overview of directors’ duties and guidance on preserving value in your business.  Rhys will then conclude the session by looking at key issues arising from business restructures and key redundancy considerations employers should be aware of. \nThis webinar will therefore cover:\n-Important director duties \n-Business restructuring and ways to preserve value in your business \n-Redundancy procedures and consultation \n-Redundancy v. furlough \nThis webinar is open to Life Science businesses who are seeking to learn about preserving value in your business and carrying our redundancy processes correctly and who wish to ask questions directly to the experts. \nDURATION: 1 hour\nThis free to attend webinar will be held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles \nSean Moran\, Partner – Shakespeare Martineau \nSean is a partner at SHMA acting for insolvency practitioners\, companies and individuals on all aspects of insolvency\, restructuring and turnaround. His practice covers both contentious and non-contentious assignments\, providing advice to directors on their duties and responsibilities as well as undertaking transactional work and insolvency-related litigation. \n  \n  \n \n  \nRhys Wyborn\, Partner\, Shakespeare Martineau\nRhys is an employment law specialist helping employers manage their staff and HR issues from recruitment through to termination of the employment relationship\, with everything in between! Specialisms include: – handling disciplinary and grievance issues; defending unfair dismissal and discrimination claims; redundancy and business reorganisations; TUPE transfers and corporate support; drafting bespoke employment contracts and HR policies. He is also regularly instructed to advise on severance agreements for senior executives and other employees\, including the drafting of terms and negotiating matters to a conclusion. Rhys also provides training on HR issues via seminars and forums and bespoke training events for clients including Mock Tribunals and managing investigations.
URL:https://staging.medilinkmidlands.com/event/webinar-business-re-organisation-to-protect-your-assets-and-to-manage-staffing-issues/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Sean_Moran2-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200625T140000
DTEND;TZID=Europe/London:20200625T150000
DTSTAMP:20260410T114231
CREATED:20200518T135807Z
LAST-MODIFIED:20200518T135807Z
UID:18187-1593093600-1593097200@staging.medilinkmidlands.com
SUMMARY:Webinar: Materials for Virus Binding and RNA Vaccine Formations
DESCRIPTION:The coronavirus crisis has resulted in an unprecedented acceleration of efforts to develop vaccines. This webinar will cover some of the basic concepts underlying nucleic acid vaccines\, and how new materials and formulations might change the way in which vaccines are made and distributed. \nKey questions to be addressed include:\n-Why does it take so long to make a new vaccine?\n-How might DNA and RNA vaccines disrupt the current process?\n-In what ways could the SME sector contribute when vaccines have traditionally been dominated by Big Pharma?\n-What are the risks on the way? \nThe webinar will also include the opportunity to pose your questions to our presenter from the University of Nottingham.  \nDURATION: 1 hour \nPRICING: Free of charge \nThis free to attend webinar will be held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profile: \n \nProfessor Cameron Alexander\, Professor of Polmer Therapeutics/Royal Society Wolfson Research Merit Fellow\, School of Pharmacy\, University of Nottingham. \nCameron a Fellow of the Royal Society of Chemistry and received the UK Macro Group Medal in 2014 for contributions to polymer science. Research interests cover the use of polymers as carriers for drug\, gene and cell delivery\, with applications ranging from antimicrobial materials to cancer therapies and vaccines.
URL:https://staging.medilinkmidlands.com/event/webinar-materials-for-virus-binding-and-rna-vaccine-formations/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Cameron-Alexander.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
END:VCALENDAR